Not yet recruiting
Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer
NCT05841849
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- the Second Affiliated Hospital of Zhejiang Univercity School of Medicine Hanzhou, Zhejiang, China